Maze Therapeutics reported total assets of $531.62M and total liabilities of $78.50M for the quarter ended Jun 2026, up 75.2% year over year. This balance sheet covers 10 quarters of results from Mar 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 16.87M | 19.21M | ||||||||
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash & EquivalentsCash & Equiv. | 30.02M | 175.06M | 149.61M | 196.81M | 294.37M | 264.54M | 316.77M | 189.25M | 198.77M | 202.64M |
| Receivables - NetNet Receivables | 20.00M | |||||||||
| Receivables - OtherOther Receivables | 0.70M | 1.50M | 1.80M | 2.80M | ||||||
| Receivables | 21.80M | |||||||||
| Prepaid Assets | 4.86M | 5.33M | 6.61M | 7.37M | 7.80M | 7.40M | 9.34M | |||
| Current Assets | 201.67M | 299.71M | 271.15M | 391.30M | 349.72M | 379.78M | 420.42M | |||
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment (Net) | 6.67M | 6.31M | 6.01M | 5.54M | 5.04M | 4.68M | 4.39M | |||
| Long-Term Investments | 18.11M | 10.56M | 83.82M | |||||||
| Other Non-Current Assets | 7.87M | 1.09M | 1.09M | 3.21M | 3.05M | 4.32M | 3.46M | |||
| Non-Current Assets | 38.87M | 33.13M | 32.37M | 30.76M | 47.41M | 39.93M | 111.20M | |||
| Assets | 240.54M | 332.84M | 303.52M | 422.06M | 397.13M | 419.71M | 531.62M | |||
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payables | 1.94M | 2.40M | 3.67M | 2.92M | 1.79M | 4.01M | 2.21M | |||
| Payables | 1.94M | 2.40M | 3.67M | 2.92M | 1.79M | 4.01M | 2.21M | |||
| Accumulated Expenses | 14.10M | 11.54M | 11.52M | 14.43M | 15.97M | 12.38M | 15.87M | |||
| Other Accumulated Expenses | 2.93M | 4.95M | 5.07M | 4.30M | 5.04M | 7.01M | ||||
| Current Leases | 4.63M | 4.67M | 4.72M | 4.76M | 4.79M | 4.84M | 4.88M | |||
| Total Current Liabilities | 20.67M | 18.62M | 19.90M | 22.11M | 22.56M | 21.24M | 22.96M | |||
| Non-Current Liabilities | ||||||||||
| Non-Current Debt | 38.83M | 38.96M | ||||||||
| Preferred Stock Liabilities | 383.90M | 383.90M | 383.90M | 508.09M | ||||||
| Operating Leases | 22.00M | 21.15M | 20.29M | 19.42M | 18.51M | 17.55M | 16.58M | |||
| Other Non-Current Liabilities | 0.97M | 1.01M | 1.09M | 1.09M | 1.09M | 0.39M | ||||
| Total Non-Current Liabilities | 42.67M | 39.77M | 40.19M | 41.53M | 41.07M | 77.62M | ||||
| Total Liabilities | 403.66M | 262.37M | 284.53M | 43.64M | 40.77M | 41.28M | 42.62M | 42.16M | 78.01M | 78.50M |
| Shareholder's Equity | ||||||||||
| Total Debt | 38.83M | 38.96M | ||||||||
| Common Equity | -403.66M | -262.37M | -284.53M | -311.18M | 292.07M | 262.24M | 379.44M | 354.97M | 341.70M | 453.12M |
| Liabilities and Shareholders Equity | 240.54M | 332.84M | 303.52M | 422.06M | 397.13M | 419.71M | 531.62M | |||
| Retained Earnings | -358.43M | 683.24M | 687.09M | 834.30M | 844.35M | 855.54M | 1,011.99M | |||
| Treasury Shares | 203.42M | 203.42M | 203.42M | 297.21M |